Covid 19 Vaccine study - at Synexus in Hexham General Hospital
This is a new trial by Novavax (USA) of a vaccine and has seen promising results thus far. The trial is at Phase 3 stage. This trial is being run alongside the National Institute for Health Research. This vaccine has been mentioned several times on the BBC and Sky News
The treatment is a “Recombinant Spike Protein Nanoparticle Vaccine,
with an adjuvant” it replicates the Corona Virus and stimulates the creation of antibodies to create resistance and immunity to the virus.
Volunteers need to be healthy or with stable medical conditions. There are 2 vaccinations, 3-4 weeks apart and then follow-up for up to 12 months from enrolment. Participants will be assessed if they develop symptoms suspicious of COVID-19. Phase 1/2 trials have shown evidence of efficacy and no serious side effects have so far being reported. Participants will need to keep an electronic diary of any symptoms and attend the Hexham site on a number of occasions. Synexus will cover transport/parking costs.
If you are over 18, you may be eligible for the study so if you are interested in taking part, please call: 01434 408750 and quote ref 19009321
Visit: HEXHAM https://www.synexusclinic.co.uk/conditions/covid-19-and-coronavirus
Right click and select open hyperlink
PRINCIPLE – COVID-related research for symptomatic patients.
https://www.principletrial.org/participants/how-to-join-the-trial
Participants can be recruited into PRINCIPLE opportunistically or by invitation (using text invite) or can register online at www.principletrial.org or by calling the Trial Office on
0800 138 0880. Swabs and medication are sent directly to the participant from the Oxford CTU.
Did you know that this practice is a research active site?
What does this mean for you?
This could mean that you are invited to take part in research which might happen at the practice or it could be at a local hospital.
If you agree to take part, and the choice is yours, you will be contributing to advances in treatments, interventions and understanding of diseases.
You will also be paid any expenses you experience from being involved.
Quotes from patients in this area who have been involved in research:
“Could help people in the future.”
“I thought my researcher was friendly and made me feel comfortable. I like to think I would be helping other people with depression by taking part"
Why does the practice think this is important?
It shows our commitment to good quality care and how that might be improved.
It enables the practice to have access to opportunities for patients and sometimes training for staff which otherwise we would not have and through this we are offering a better service to patients.
If you are interested in knowing more about the sorts of things we do here get in touch with Anne Brooks.
COPD and Asthma |
Study | Aim |
| |
ARRISA
INTREPID | Monitoring how the practice manages its asthmatic patients to ascertain how severe attacks can be prevented.
COPD management |
Pain Control |
I-Wotch | Managing pain control |
Mental Health |
| None at present |
Cardiology |
Garfield | Observing behaviour on patients newly-diagnosed with Atrial Fibrillation |
Urinary Symptoms |
PRIMUS | Management of lower urinary tract symptoms in men |
|